Cargando…
Pathophysiological basis of the cardiological benefits of SGLT-2 inhibitors: a narrative review
In recent years, GLP-1 receptor agonists (GLP-1RA), and SGLT-2 inhibitors (SGLT-2i) have become available, which have become valuable additions to therapy for type 2 diabetes as they are associated with low risk for hypoglycemia and cardiovascular benefits. Indeed, SGLT-2i have emerged as a promisin...
Autores principales: | Panico, Cristina, Bonora, Benedetta, Camera, Antonella, Chilelli, Nino Cristiano, Prato, Giuliana Da, Favacchio, Giuseppe, Grancini, Valeria, Resi, Veronica, Rondinelli, Maurizio, Zarra, Emanuela, Pintaudi, Basilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314539/ https://www.ncbi.nlm.nih.gov/pubmed/37391739 http://dx.doi.org/10.1186/s12933-023-01855-y |
Ejemplares similares
-
Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence
por: Bonora, Benedetta Maria, et al.
Publicado: (2020) -
Etiopathogenesis and Pathophysiology of Malaria
por: Giribaldi, Giuliana, et al.
Publicado: (2014) -
The Emerging Role of Telemedicine in Managing Glycemic Control and Psychobehavioral Aspects of Pregnancy Complicated by Diabetes
por: Chilelli, Nino Cristiano, et al.
Publicado: (2014) -
SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system
por: Bonora, Benedetta Maria, et al.
Publicado: (2021) -
Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study
por: Piccini, Sara, et al.
Publicado: (2023)